Back
AbCellera Biologics Vs. Aurinia Pharmaceuticals Industry Stock Comparison
Buy
60
ABCL
AbCellera Biologics
Last Price:
2.81
Seasonality Move:
-23.52%
Buy
72
AUPH
Aurinia Pharmaceuticals
Last Price:
9.38
Seasonality Move:
15.65%
Buy
60
AbCellera Biologics (ABCL)
is a Buy
Is AbCellera Biologics a Buy, Sell or Hold?
- The current AbCellera Biologics [ABCL] share price is $2.81. The Score for ABCL is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- ABCL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
72
Aurinia Pharmaceuticals (AUPH)
is a Buy
Is Aurinia Pharmaceuticals a Buy, Sell or Hold?
- The current Aurinia Pharmaceuticals [AUPH] share price is $9.37. The Score for AUPH is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- AUPH is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ABCL Stock Price Chart
What is AbCellera Biologics's stock price today?
-
The AbCellera Biologics share price today is $2.81
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABCL is experiencing selling pressure, which indicates risk of future bearish movement.
AUPH Stock Price Chart
What is Aurinia Pharmaceuticals's stock price today?
-
The Aurinia Pharmaceuticals share price today is $9.37
The current trend is moderately bullish and AUPH is experiencing slight selling pressure.
ABCL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.04 | Buy |
Relative Strength Index (14 RSI): | 47.51 | Sell |
Chaikin Money Flow: | -2108907 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.74 - 3) | Sell |
Bollinger Bands (100): | (2.53 - 2.93) | Buy |
AUPH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.48 | Buy |
Relative Strength Index (14 RSI): | 58.76 | Buy |
Chaikin Money Flow: | -453168 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.22 - 9.4) | Buy |
Bollinger Bands (100): | (6.11 - 8.35) | Buy |
ABCL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.92 | Sell |
20-day SMA: | 2.86 | Sell |
50-day SMA: | 2.78 | Buy |
200-day SMA: | 3.3 | Sell |
8-day EMA: | 2.91 | Sell |
20-day EMA: | 2.89 | Sell |
50-day EMA: | 2.82 | Sell |
200-day EMA: | 3.38 | Sell |
AUPH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.41 | Sell |
20-day SMA: | 8.92 | Buy |
50-day SMA: | 8 | Buy |
200-day SMA: | 6.27 | Buy |
8-day EMA: | 9.46 | Sell |
20-day EMA: | 9 | Buy |
50-day EMA: | 8.24 | Buy |
200-day EMA: | 7.15 | Buy |
AbCellera Biologics Earnings Growth & ABCL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.13 per share, and a decrease next year of $0.08 per share.
Aurinia Pharmaceuticals Earnings Growth & AUPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and an increase next year of $0.54 per share.
AbCellera Biologics Technical Analysis
Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aurinia Pharmaceuticals Technical Analysis
Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |